secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardian Pharmacy Services, Inc. (GRDN)
CIK:        0001802255
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001193125-26-208989
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardian Pharmacy Q1 revenue $336.6M (+2% YoY); raises FY Adjusted EBITDA guidance to $123-127M
--------------------------------------------------------------------------------

- Revenue $336.6M (+2% YoY); residents served 207K (+10% YoY). Net income $13.5M vs $9.3M.
- Adjusted EBITDA $29.8M vs $23.4M; diluted EPS $0.21, adjusted EPS $0.29.
- FY 2026 guidance: revenue unchanged $1.40-1.42B; Adjusted EBITDA raised to $123-127M from $120-124M.
- Cash $64.9M, no debt on credit facility; completed non-dilutive secondary offering of 6.9M shares in March 2026.
- Company offset IRA pricing resets, maintaining margin stability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802255/000119312526208989/0001193125-26-208989-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802255/000119312526208989/d132626d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-208989

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer